Relationship Between the Direct Medical Costs and Direct Non-Medical Costs of Parkinson's Disease According to Disease Severity During 4 Years of Follow-Up in Spain.

Martinez, P; Rodriguez-Blazquez, C; Paz, S; Lizán, L; Forjaz, M J; Frades, B; Moreno, R

Martinez, P; Rodriguez-Blazquez, C; Paz, S; Lizán, L; Forjaz, M J; Frades, B; Moreno, R.

Afiliación

Martinez P; National Center for Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Rodriguez-Blazquez C; National Center for Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Paz S; Outcomes'10, Castellon, Spain.
Lizán L; Outcomes 10, Castellon, Spain.
Forjaz MJ; National School of Public Health and REDISSEC, Carlos III Institute of Health, Madrid, Spain.
Frades B; Alzheimer Center Reina Sofia Foundation, Carlos III Institute of Health, Madrid, Spain.
Moreno R; Infanta Cristina Hospital, Madrid, Spain.

Value Health ; 17(7): A395, 2014 Nov.

Article en En | MEDLINE | ID: mdl-27200925

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: España

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google